MCPyV− MCCs also consistently harbor mutations that inactivate the tumor suppressor genes RB1 and TP53 [113,114,115], suggesting that these mutations and their downstream effects are the primary drivers of oncogenesis in MCPyV− MCC. This evidence concerns the gene TP53 and Merkel cell skin cancer.